99% Savings - Buy Just @1 Rs X
Zidolam Ecopack Tablet is a prescription drug, available for use as Tablet. Secondary and off-label uses of Zidolam Ecopack Tablet have also been mentioned below.
The optimal dosage of Zidolam Ecopack Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
While these are the most often observed Zidolam Ecopack Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Zidolam Ecopack Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Zidolam Ecopack Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Zidolam Ecopack Tablet's effects on the liver, heart and kidney are discussed below in the Zidolam Ecopack Tablet related warnings section.
Zidolam Ecopack Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Pancreatitis, Kidney Disease are examples of such conditions. Other contraindications of Zidolam Ecopack Tablet have been discussed in the sections ahead.
Besides this, Zidolam Ecopack Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Zidolam Ecopack Tablet is not safe while driving, and is not addiction.
Zidolam Ecopack Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Zidolam Ecopack Tablet safe for pregnant women?
Zidolam can have harmful effects in pregnant women. If you experience any discomfort after using Zidolam, then discontinue the use and take your doctor's advice.
Is the use of Zidolam Ecopack Tablet safe during breastfeeding?
Zidolam may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Zidolam, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Zidolam.
What is the effect of Zidolam Ecopack Tablet on the Kidneys?
Very few cases of side effects of Zidolam on kidney have been reported.
What is the effect of Zidolam Ecopack Tablet on the Liver?
Very few cases of side effects of Zidolam on the liver have been reported.
What is the effect of Zidolam Ecopack Tablet on the Heart?
Side effects of Zidolam rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Zidolam Ecopack Tablet unless your doctor advises you to do so -
Is this Zidolam Ecopack Tablet habit forming or addictive?
No, there is no any evidence that Zidolam Ecopack Tablet is addictive.
Interaction between Food and Zidolam Ecopack Tablet
You can take Zidolam Ecopack Tablet with food.
Interaction between Alcohol and Zidolam Ecopack Tablet
Consuming Zidolam Ecopack Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retrovir® (zidovudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 806-807
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1286-1288